Comparison of safety and mortality of infliximab therapy to immunomodulator therapy in Crohn's disease: A cohort study

被引：3
|
作者：
Doumit, J [1 ]
Brzezinski, A [1 ]
Lashner, B [1 ]
Achkar, JP [1 ]
Lopez, R [1 ]
Shen, B [1 ]
机构：
[1] Cleveland Clin, Ctr Inflammatory Bowel Dis, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00829
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S306 / S306
页数：1
相关论文
共 50 条
  • [1] Infliximab therapy in Crohn's disease: safety issues
    Hommes, DW
    van Deventer, SJH
    NETHERLANDS JOURNAL OF MEDICINE, 2003, 61 (04): : 100 - 104
  • [2] Concomitant Immunomodulator and Infliximab Therapy for Crohn's Disease: A Survey of Physician Practice
    Vajravelu, Ravy
    Katz, Jeffry
    GASTROENTEROLOGY, 2010, 138 (05) : S702 - S702
  • [3] Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
    Kwak, Min Seob
    Kim, Kyung-Jo
    Cheon, Jae Hee
    Kim, Wan Soo
    Lee, Jeong-Mi
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [4] Infliximab use in children with Crohn disease: Relationship to immunomodulator therapy
    Hyams, Jeffrey
    Kugathasan, Subra
    Lerer, Trudy
    Griffiths, Anne M.
    Otley, Anthony
    Pfefferkorn, Marian D.
    Moyer, M. susan
    Leleiko, Neal S.
    Evans, Jonathan S.
    Mack, David R.
    Wyllie, Robert
    Rosh, Joel R.
    Markowitz, James F.
    GASTROENTEROLOGY, 2007, 132 (04) : A659 - A659
  • [5] Perioperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease
    Colombel, JF
    Loftus, EV
    Tremaine, WJ
    Pemberton, JH
    Wolff, BG
    Young-Fadok, T
    Harmsen, WS
    Schleck, CG
    Sandborn, WJ
    GASTROENTEROLOGY, 2003, 124 (04) : A521 - A521
  • [6] Intensification of infliximab therapy in Crohn's disease: Efficacy and safety
    Chaparro, M.
    Martinez-Montiel, P.
    Van Domselaar, M.
    Bermejo, F.
    Perez-Calle, J. L.
    Casis, B.
    Lopez-San Roman, A.
    Algaba, A.
    Mate, J.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (01): : 62 - 67
  • [7] Concurrent immunomodulator therapy in Crohn's disease; Does it improve initial response to infliximab?
    Weinberg, AM
    Lewis, JD
    Sit, CG
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S254 - S254
  • [8] Infliximab Versus Immunomodulator as First Maintenance Therapy in Children With Crohn Disease
    Markowitz, James
    Evans, Jonathan
    Pfefferkorn, Marian D.
    Griffiths, Anne M.
    Keljo, David J.
    Mack, David R.
    Carvalho, Ryan
    Leleiko, Neal S.
    Otley, Anthony R.
    Rosh, Joel R.
    Stephens, Michael C.
    Saeed, Shehzad A.
    Ashai-Khan, Farhat N.
    Bousvaros, Athos
    Kay, Marsha H.
    Oliva-Hemker, Maria
    Grossman, Andrew B.
    Sudel, Boris
    Kappelman, Michael
    Dimmitt, Reed A.
    Langton, Christine R.
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2012, 142 (05) : S349 - S349
  • [9] Intensification of infliximab (Ifx) therapy in Crohn's disease:: Efficacy and safety
    Chaparro, Maria
    Martinez-Montiel, P.
    Van Domselaar, Manuel
    Bermejo, Fernando
    Perez-Calle, Jl
    Casis, B.
    Roman, Antonio Lopez-San
    Algaba, Alicia
    Mate-Jimenez, Jose
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2008, 134 (04) : A664 - A664
  • [10] Safety and efficacy of infliximab therapy in HIV patients with Crohn's disease
    Tessnow, K
    Chiao, L
    Jamjian, C
    Ries, K
    GASTROENTEROLOGY, 2002, 122 (04) : A616 - A616
12345